418 related articles for article (PubMed ID: 34012113)
21. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
Stancu IC; Ferraiolo M; Terwel D; Dewachter I
Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
[TBL] [Abstract][Full Text] [Related]
22. Different tau species lead to heterogeneous tau pathology propagation and misfolding.
Dujardin S; Bégard S; Caillierez R; Lachaud C; Carrier S; Lieger S; Gonzalez JA; Deramecourt V; Déglon N; Maurage CA; Frosch MP; Hyman BT; Colin M; Buée L
Acta Neuropathol Commun; 2018 Nov; 6(1):132. PubMed ID: 30497516
[TBL] [Abstract][Full Text] [Related]
23. Different MAPT haplotypes influence expression of total MAPT in postmortem brain tissue.
Tauber CV; Schwarz SC; Rösler TW; Arzberger T; Gentleman S; Windl O; Krumbiegel M; Reis A; Ruf VC; Herms J; Höglinger GU
Acta Neuropathol Commun; 2023 Mar; 11(1):40. PubMed ID: 36906636
[TBL] [Abstract][Full Text] [Related]
24. Tau drives translational selectivity by interacting with ribosomal proteins.
Koren SA; Hamm MJ; Meier SE; Weiss BE; Nation GK; Chishti EA; Arango JP; Chen J; Zhu H; Blalock EM; Abisambra JF
Acta Neuropathol; 2019 Apr; 137(4):571-583. PubMed ID: 30759285
[TBL] [Abstract][Full Text] [Related]
25. The novel MAPT mutation K298E: mechanisms of mutant tau toxicity, brain pathology and tau expression in induced fibroblast-derived neurons.
Iovino M; Pfisterer U; Holton JL; Lashley T; Swingler RJ; Calo L; Treacy R; Revesz T; Parmar M; Goedert M; Muqit MM; Spillantini MG
Acta Neuropathol; 2014 Feb; 127(2):283-95. PubMed ID: 24292008
[TBL] [Abstract][Full Text] [Related]
26. Pathogenic MAPT mutations Q336H and Q336R have isoform-dependent differences in aggregation propensity and microtubule dysfunction.
Xia Y; Nasif L; Giasson BI
J Neurochem; 2021 Jul; 158(2):455-466. PubMed ID: 33772783
[TBL] [Abstract][Full Text] [Related]
27. Integrative system biology analyses of CRISPR-edited iPSC-derived neurons and human brains reveal deficiencies of presynaptic signaling in FTLD and PSP.
Jiang S; Wen N; Li Z; Dube U; Del Aguila J; Budde J; Martinez R; Hsu S; Fernandez MV; Cairns NJ; ; ; Harari O; Cruchaga C; Karch CM
Transl Psychiatry; 2018 Dec; 8(1):265. PubMed ID: 30546007
[TBL] [Abstract][Full Text] [Related]
28. Generation of a human induced pluripotent stem cell-based model for tauopathies combining three microtubule-associated protein TAU mutations which displays several phenotypes linked to neurodegeneration.
García-León JA; Cabrera-Socorro A; Eggermont K; Swijsen A; Terryn J; Fazal R; Nami F; Ordovás L; Quiles A; Lluis F; Serneels L; Wierda K; Sierksma A; Kreir M; Pestana F; Van Damme P; De Strooper B; Thorrez L; Ebneth A; Verfaillie CM
Alzheimers Dement; 2018 Oct; 14(10):1261-1280. PubMed ID: 30036493
[TBL] [Abstract][Full Text] [Related]
29. MAPT expression and splicing is differentially regulated by brain region: relation to genotype and implication for tauopathies.
Trabzuni D; Wray S; Vandrovcova J; Ramasamy A; Walker R; Smith C; Luk C; Gibbs JR; Dillman A; Hernandez DG; Arepalli S; Singleton AB; Cookson MR; Pittman AM; de Silva R; Weale ME; Hardy J; Ryten M
Hum Mol Genet; 2012 Sep; 21(18):4094-103. PubMed ID: 22723018
[TBL] [Abstract][Full Text] [Related]
30. MAPT subhaplotypes in corticobasal degeneration: assessing associations with disease risk, severity of tau pathology, and clinical features.
Valentino RR; Koga S; Walton RL; Soto-Beasley AI; Kouri N; DeTure MA; Murray ME; Johnson PW; Petersen RC; Boeve BF; Uitti RJ; Wszolek ZK; Dickson DW; Ross OA; Heckman MG
Acta Neuropathol Commun; 2020 Dec; 8(1):218. PubMed ID: 33287913
[TBL] [Abstract][Full Text] [Related]
31. Tau pathology is present in vivo and develops in vitro in sensory neurons from human P301S tau transgenic mice: a system for screening drugs against tauopathies.
Mellone M; Kestoras D; Andrews MR; Dassie E; Crowther RA; Stokin GB; Tinsley J; Horne G; Goedert M; Tolkovsky AM; Spillantini MG
J Neurosci; 2013 Nov; 33(46):18175-89. PubMed ID: 24227726
[TBL] [Abstract][Full Text] [Related]
32. Altered Proteostasis in Neurodegenerative Tauopathies.
Papanikolopoulou K; Skoulakis EMC
Adv Exp Med Biol; 2020; 1233():177-194. PubMed ID: 32274757
[TBL] [Abstract][Full Text] [Related]
33. The human MAPT locus generates circular RNAs.
Welden JR; van Doorn J; Nelson PT; Stamm S
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2753-2760. PubMed ID: 29729314
[TBL] [Abstract][Full Text] [Related]
34. Threonine
Moszczynski AJ; Yang W; Hammond R; Ang LC; Strong MJ
Acta Neuropathol Commun; 2017 Jan; 5(1):6. PubMed ID: 28077166
[TBL] [Abstract][Full Text] [Related]
35. Generation of 17q21.31 duplication iPSC-derived neurons as a model for primary tauopathies.
Miguel L; Rovelet-Lecrux A; Chambon P; Joly-Helas G; Rousseau S; Wallon D; Epelbaum S; Frébourg T; Campion D; Nicolas G; Lecourtois M
Stem Cell Res; 2022 May; 61():102762. PubMed ID: 35358831
[TBL] [Abstract][Full Text] [Related]
36. Impaired tau-microtubule interactions are prevalent among pathogenic tau variants arising from missense mutations.
Xia Y; Sorrentino ZA; Kim JD; Strang KH; Riffe CJ; Giasson BI
J Biol Chem; 2019 Nov; 294(48):18488-18503. PubMed ID: 31653695
[TBL] [Abstract][Full Text] [Related]
37. The role of MAPT sequence variation in mechanisms of disease susceptibility.
Caffrey TM; Wade-Martins R
Biochem Soc Trans; 2012 Aug; 40(4):687-92. PubMed ID: 22817717
[TBL] [Abstract][Full Text] [Related]
38. Pathological Tau Promotes Neuronal Damage by Impairing Ribosomal Function and Decreasing Protein Synthesis.
Meier S; Bell M; Lyons DN; Rodriguez-Rivera J; Ingram A; Fontaine SN; Mechas E; Chen J; Wolozin B; LeVine H; Zhu H; Abisambra JF
J Neurosci; 2016 Jan; 36(3):1001-7. PubMed ID: 26791227
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathologic heterogeneity in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) due to microtubule-associated protein tau (MAPT) p.P301L mutation, including a patient with globular glial tauopathy.
Tacik P; Sanchez-Contreras M; DeTure M; Murray ME; Rademakers R; Ross OA; Wszolek ZK; Parisi JE; Knopman DS; Petersen RC; Dickson DW
Neuropathol Appl Neurobiol; 2017 Apr; 43(3):200-214. PubMed ID: 27859539
[TBL] [Abstract][Full Text] [Related]
40. Kinetics of Human Mutant Tau Prion Formation in the Brains of 2 Transgenic Mouse Lines.
Woerman AL; Patel S; Kazmi SA; Oehler A; Freyman Y; Espiritu L; Cotter R; Castaneda JA; Olson SH; Prusiner SB
JAMA Neurol; 2017 Dec; 74(12):1464-1472. PubMed ID: 29059326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
